OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
Frank Cichocki, Sjoukje J. C. van der Stegen, Jeffrey S. Miller
Blood (2022) Vol. 141, Iss. 8, pp. 846-855
Open Access | Times Cited: 46
Frank Cichocki, Sjoukje J. C. van der Stegen, Jeffrey S. Miller
Blood (2022) Vol. 141, Iss. 8, pp. 846-855
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Allogeneic natural killer cell therapy
Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger
Blood (2022) Vol. 141, Iss. 8, pp. 856-868
Open Access | Times Cited: 114
Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger
Blood (2022) Vol. 141, Iss. 8, pp. 856-868
Open Access | Times Cited: 114
T-BET and EOMES sustain mature human NK cell identity and antitumor function
Pamela Wong, Jennifer A. Foltz, Lily Chang, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 27
Pamela Wong, Jennifer A. Foltz, Lily Chang, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 27
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors
Tobias Bexte, Lacramioara Botezatu, Csaba Miskey, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2357-2372
Closed Access | Times Cited: 12
Tobias Bexte, Lacramioara Botezatu, Csaba Miskey, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2357-2372
Closed Access | Times Cited: 12
Exosome-based nanoparticles and cancer immunotherapy
Jiarong Ye, Danni Li, Yiting Jie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117296-117296
Open Access | Times Cited: 10
Jiarong Ye, Danni Li, Yiting Jie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117296-117296
Open Access | Times Cited: 10
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies
Quirin Hammer, Karlo Perica, Rina M. Mbofung, et al.
Cell stem cell (2024) Vol. 31, Iss. 9, pp. 1376-1386.e8
Open Access | Times Cited: 9
Quirin Hammer, Karlo Perica, Rina M. Mbofung, et al.
Cell stem cell (2024) Vol. 31, Iss. 9, pp. 1376-1386.e8
Open Access | Times Cited: 9
Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine
Lingxi Wei, Wenqi Yan, Wahid Shah, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35836-e35836
Open Access | Times Cited: 8
Lingxi Wei, Wenqi Yan, Wahid Shah, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35836-e35836
Open Access | Times Cited: 8
Engineering innate immune cells for cancer immunotherapy
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access | Times Cited: 1
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access | Times Cited: 1
Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer
Ye Li, Katayoun Rezvani, Hind Rafei
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 217-235
Open Access | Times Cited: 21
Ye Li, Katayoun Rezvani, Hind Rafei
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 217-235
Open Access | Times Cited: 21
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 8
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 8
Allogeneic “Off-the-Shelf” CAR T Cells: Challenges and Advances
Sophia Chen, Marcel R.M. van den Brink
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 3, pp. 101566-101566
Closed Access | Times Cited: 7
Sophia Chen, Marcel R.M. van den Brink
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 3, pp. 101566-101566
Closed Access | Times Cited: 7
Synthetic macromolecular switches for precision control of therapeutic cell functions
Ana P. Teixeira, Martin Fussenegger
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 7
Ana P. Teixeira, Martin Fussenegger
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 7
Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges
Jun Kong, Mohammad Auwal Sa’ad, Hema Manusri Vijayan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Jun Kong, Mohammad Auwal Sa’ad, Hema Manusri Vijayan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
Kristin M. Snyder, Kate Dixon, Zachary Davis, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007280-e007280
Open Access | Times Cited: 13
Kristin M. Snyder, Kate Dixon, Zachary Davis, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007280-e007280
Open Access | Times Cited: 13
Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy
Teng Zhang, Cheng Qian, Mengyao Song, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2680-2680
Open Access | Times Cited: 5
Teng Zhang, Cheng Qian, Mengyao Song, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2680-2680
Open Access | Times Cited: 5
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 5
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 5
Universal CAR 2.0 to overcome current limitations in CAR therapy
Lara Sophie Schlegel, Coralie Werbrouck, Michael Boettcher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Lara Sophie Schlegel, Coralie Werbrouck, Michael Boettcher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Potency assays and biomarkers for cell-based advanced therapy medicinal products
Chiara Capelli, Carolina Cuofano, Chiara Pavoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Chiara Capelli, Carolina Cuofano, Chiara Pavoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
The Challenges to Advancing Induced Pluripotent Stem Cell-Dependent Cell Replacement Therapy
Alan B. Moy, Anant Kamath, Sara Ternes, et al.
Medical Research Archives (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 11
Alan B. Moy, Anant Kamath, Sara Ternes, et al.
Medical Research Archives (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 11
Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma
Seung Kak Shin, Y. Mishima, Yoonseok Lee, et al.
Journal of Gastroenterology and Hepatology (2025)
Open Access
Seung Kak Shin, Y. Mishima, Yoonseok Lee, et al.
Journal of Gastroenterology and Hepatology (2025)
Open Access
The key role of immunomodulatory cytokines for the development of novel NK cell-based cancer therapies
A.A. Câmara, Diego Barriales, Ainara Azueta Etxebarría, et al.
International review of cell and molecular biology (2025)
Closed Access
A.A. Câmara, Diego Barriales, Ainara Azueta Etxebarría, et al.
International review of cell and molecular biology (2025)
Closed Access
Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma
Mayuna Nakamura, Yuka Tanaka, Keishi Hakoda, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Mayuna Nakamura, Yuka Tanaka, Keishi Hakoda, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Cellular Kinetics and Biodistribution of Adoptive T Cell Therapies: from Biological Principles to Effects on Patient Outcomes
Ran Li, Abigail K. Grosskopf, Louis R. Joslyn, et al.
The AAPS Journal (2025) Vol. 27, Iss. 2
Open Access
Ran Li, Abigail K. Grosskopf, Louis R. Joslyn, et al.
The AAPS Journal (2025) Vol. 27, Iss. 2
Open Access
A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors
Dequan Liu, Lei Liu, Xinming Zhao, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104702-104702
Open Access
Dequan Liu, Lei Liu, Xinming Zhao, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104702-104702
Open Access
The clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Enhancing the physiological characteristics of chimeric antigen receptor natural killer cells by synthetic biology
So Young Ji, Cheng Jin, Xuewei Cui
Frontiers in Immunology (2025) Vol. 16
Open Access
So Young Ji, Cheng Jin, Xuewei Cui
Frontiers in Immunology (2025) Vol. 16
Open Access
